• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10620
Device Problem Material Deformation (2976)
Patient Problem No Patient Involvement (2645)
Event Date 08/06/2020
Event Type  malfunction  
Manufacturer Narrative
Initial reporter city: (b)(6).
 
Event Description
It was reported that stent damage occurred.The 90% stenosed target lesion was located in the mildly tortuous and severely calcified mid left anterior descending artery.A 2.50 x 24 synergy drug-eluting stent was selected for use.However, when trying to insert the stent into the guidewire, the distal part of the stent was noticed to be deformed.The procedure was completed with a different device.There were no patient complications reported.
 
Manufacturer Narrative
E1 - initial reporter city: (b)(6).Device evaluated by mfr.: synergy ous mr 2.50 x 24mm stent delivery system, catheter was returned for analysis.A visual examination of the stent found stent damage.The distal struts were stretched and extended towards the distal markerband.The undamaged stent outer diameter was measured and the result was within maximum crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of tip damage.A visual and tactile examination of the hypotube found no issues.A visual and tactile examination of the outer and inner lumen and mid-shaft section found no issues along the shaft polymer extrusion.No other issues were identified during the product analysis.
 
Event Description
It was reported that stent damage occurred.The 90% stenosed target lesion was located in the mildly tortuous and severely calcified mid left anterior descending artery.A 2.50 x 24 synergy drug-eluting stent was selected for use.However, when trying to insert the stent into the guidewire, the distal part of the stent was noticed to be deformed.The procedure was completed with a different device.There were no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10391782
MDR Text Key202404351
Report Number2134265-2020-10944
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 09/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/11/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/27/2021
Device Model Number10620
Device Catalogue Number10620
Device Lot Number0024732598
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/20/2020
Date Manufacturer Received09/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
GUIDE CATHETER: GUIDEPLUS; GUIDE CATHETER: GUIDEPLUS; GUIDE CATHETER: GUIDEPLUS
-
-